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resistin. Interestingly, treatment of adipocytes with two other adipo-
cytokines, adiponectin and leptin, did not lead to CRP production.
Furthermore, treatment with several anti-inflammatory drugs shown
to be effective in reducing serum CRP levels, such as aspirin,
troglitazone, and fluvastatin (10,11), leads to reduction, but not
complete inhibition, of CRP release from adipocytes. This might
explain in part the beneficial cardiovascular effects of these drugs.
In conclusion, our study demonstrates that human adipocytes
can produce CRP under the stimulation of several proinflamma-
tory cytokines; moreover, CRP production may be modulated by
selected pharmacologic intervention. The mechanism(s) underly-
ing these findings are not fully defined, and further studies are
needed in this area.
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Letters to the Editor
Physiological Mechanisms of
Atrially Induced Heart Rate Turbulence
We read with interest the study by Vikman et al. (1) and are pleased
that this respectable group shares our interest in atrially induced heart
rate turbulence. Although we understand the reasoning behind the
suggestion that “vagal inhibition in response to premature atrial
excitation is absent, or even that transient enhancement of vagal
outflow occurs before atrial fibrillation,” we would like to offer the
investigators an alternative explanation for their findings.
We all would surely agree that less effective ventricular contraction
and compensatory pause after premature beats is responsible for
transient hemodynamic deficit, missed baroreflex afferent input, and
early vagal inhibition. This mechanism is applicable for both ventric-
ular and atrial premature complexes (APCs). Autonomic modulation
of sinus nodal discharge after APCs may explain values of turbulence
onset (TO) 0. When TO 0 is found, the underlying mechanism
has to be different. The mechanism suggested by Vikman et al.,
namely the temporary direct suppression of sinus node automaticity, is
certainly plausible. This phenomenon, which may mask (or over-
whelm) the autonomic component of early acceleration, has been
previously demonstrated (2).
Because of a missing relationship between TO and APC prema-
turity, Vikman et al. rejected the hypothesis that sinus resetting is the
predominant factor influencing the temporal changes of TO. How-
ever, this lack of correlation seems to us compatible rather than
incompatible with sinus nodal resetting. Autonomically mediated TO
should be positively related to the APC coupling interval, whereas TO
mediated by direct suppression of sinus node automaticity should be
negatively related to the APC coupling interval. Thus, coexistence of
both mechanisms may effectively offset the relationship between TO
and APC prematurity.
Although TO and turbulence slope after ventricular premature
complexes and turbulence slope after APCs reflect heart rate vagal
modulation, this is not the case for TO after APCs (3). We have not
found any significant relationship between atrial TO and other
previously established surrogates of heart rate vagal modulation in
large Holter databases (Wichterle et al., unpublished data, 2005).
We thus wonder whether Vikman et al. (1) would agree that their
finding might be interpreted as either 1) temporal decrease of vagal
modulation, or 2) temporal change of APC prematurity (which
cannot be exactly assessed fromHolter recording) and/or site of origin
of APCs—all factors potentially facilitating sinus node resetting. We
believe that the latter possibility might be more probable because none
of the other investigated indices of autonomic modulation (including
Figure 2. Modulation of C-reactive protein (CRP) synthesis in human
adipocytes treated with dimethylsulfoxide (DMSO) (control), fluvastatin
(FLUVA), troglitazone (TROG), or aspirin (ASA). Values are expressed
as the “-fold” increase in the level compared with the level in untreated
cells, and each bar represents the mean  SD of duplicate determinations.
*p  0.05 vs. combination of cytokines. 1  6  R  interleukin-1 
interleukin-6  resistin.
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spectral measures of heart rate variability and turbulence slope after
APCs) revealed any significant change before the onset of spontane-
ous atrial fibrillation episode.
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REPLY
We are very pleased to get an intellectual input from Wichterle
and Malik related to the mechanisms of heart rate (HR)
turbulence after atrial premature beats (APBs). The major
observation of our study (1) was that “paradoxical” increase of
R-R intervals after APBs, resulting in a positive turbulence
onset (TO), precedes the spontaneous onset of atrial fibrillation
(AF) episodes. Our interpretation was that enhanced vagal
responses to APBs might be the major factor behind this
phenomenon.
Wichterle and Malik propose another potential mechanism,
discussed also in our report, that resetting of sinus node activity
after APBs might be the possible mechanism behind the paradox-
ical TO. The resetting phenomenon might then reflect the change
in the origin or prematurity of APBs in the vicinity of AF episodes.
For example, the APBs originating from the pulmonary veins
might result in a different resetting of the sinus node.
As commented on by Wichterle and Malik, the TO after
APBs has actually no relationship with other markers of
autonomic tone measured from 24-h electrocardiograph record-
ings. This observation is consistent with our previous study (2).
However, it should be noted that tonic autonomic regulation
may be completely different from reflex regulation in response
to acute hemodynamic fluctuation. Therefore, the lack of this
correlation does not exclude the potential contribution of vagal
reflexes in response to APBs, and it is evident that we do not
seem to have enough data at the moment to precisely define the
mechanisms of HR behavior after APBs. New study designs are
needed to clarify this issue—for example, studies where APBs
are delivered from various sites of atria, including pulmonary
veins, with and without autonomic blockade.
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Genetic Testing in Clinics for Congenital
Heart Disease in Adults
We read with interest the report by Beauchesne et al. (1) regarding
22q11.2 microdeletion in adults with selected conotruncal abnormal-
ities.We have pursued a policy of screening for 22q11.2 microdeletion
in such patients who are seen in a dedicated clinic for congenital heart
disease in adults. This, however, is not a tertiary center, but a large
district United Kingdom general hospital. As such, the numbers are
smaller and have been performed as the patients come through clinic.
To date, 8 of 16 patients with pulmonary atresia ventricular septal
defect have been tested and 3 patients have 22q11.2 microdeletion
(37.5%). One of these is of Chinese ethnic origin but probably has
dysmorphic features. He had a sister who died with truncus arteriosus.
The second patient has clear dysmorphic features with mental
retardation. The third does not have dysmorphic features but is
mentally retarded. Thirty-two of 55 patients with tetralogy of Fallot
have been screened. None have 22q11.2 microdeletion, but one with
very dysmorphic features has deletion of the long arm of C11 and is
thought to have Jacobsen syndrome, which has been associated with
endocardial cushion defects and coarctation of the aorta (2); we have
not found this or 22q11.2 microdeletion in 4 of 33 patients with
endocardial cushion defects or 20 of 88 coarctation patients tested so
far. We agree with the investigators that screening of such high-risk
patients is mandatory—especially given the implications for 50%
transmission. As the genetic basis for congenital heart disease be-
comes clearer, more assiduous attention is likely to be needed,
especially for those involved in maternal medicine.
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